Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

QCLS

Q/C TECHNOLOGIES, INC.

CIK 0001321834 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$2.58
↓ 0.15 (-5.49%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$20.26M
P/E Ratio
-1.22
EPS
-8.66
Dividend Yield
Not covered
52W Position
29%
Beta
2.52

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.26
P/S
Not covered
EV/Revenue
Not covered
ROE
-102.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 29%
$0.04$8.94

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$11.63M
Total Assets
$41.17M
Free Cash Flow
–

Recent news